A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers
Pfizer
Pfizer
Adela, Inc
Tempus AI
Actuate Therapeutics Inc.
Global BioClinical
Blue Note Therapeutics
Pfizer
Celgene
LEO Pharma
Shenzhen BinDeBio Ltd.
Novartis
Novartis
Amgen